Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation

Tianyu Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Chuan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College), Shoulong Deng(Chinese Academy of Medical Sciences & Peking Union Medical College), Xue-Ling Xu(China Agricultural University), Jinhua Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuguang Du(China Agricultural University), Jianan Yu(China University of Geosciences (Beijing))
Cells
November 30, 2022
10.3390/cells11233865
Cited by 23

Related Papers

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
|Cell|2020|1.4k
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
|Viruses|2019|1.3k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Animal models for COVID-19
|Nature|2020|877
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
|The Journal of Infectious Diseases|2015|623